Cham­pi­oned by Ab­b­Vie, im­muno-neu­rol­o­gy play­er Alec­tor maps $150M IPO

En­dorsed by Ab­b­Vie, and un­der the lead­er­ship of Genen­tech vet­er­an Arnon Rosen­thal, San Fran­cis­co-based biotech Alec­tor has chart­ed a path to­ward a $150 mil­lion IPO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.